ChromaDex (ChromaDex) Days Inventory : 149.98 (As of Dec. 2023)

View and export this data going back to 2008. Start your Free Trial

What is ChromaDex Days Inventory?

Days Inventory is also known as Days Sales of Inventory (DSI). ChromaDex's Average Total Inventories for the three months ended in Dec. 2023 was $13.57 Mil. ChromaDex's Cost of Goods Sold for the three months ended in Dec. 2023 was $8.26 Mil. Hence, ChromaDex's Days Inventory for the three months ended in Dec. 2023 was 149.98.

The historical rank and industry rank for ChromaDex's Days Inventory or its related term are showing as below:

CDXC' s Days Inventory Range Over the Past 10 Years
Min: 108.51 Med: 176.55 Max: 260.41
Current: 146.28

During the past 13 years, ChromaDex's highest Days Inventory was 260.41. The lowest was 108.51. And the median was 176.55.

CDXC's Days Inventory is ranked better than
60.55% of 649 companies
in the Biotechnology industry
Industry Median: 191.36 vs CDXC: 146.28

ChromaDex's Days Inventory declined from Dec. 2022 (154.01) to Dec. 2023 (149.98).

Inventory Turnover measures how fast the company turns over its inventory within a year. ChromaDex's Inventory Turnover for the three months ended in Dec. 2023 was 0.61.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. ChromaDex's Inventory-to-Revenue for the three months ended in Dec. 2023 was 0.64.

ChromaDex Days Inventory Historical Data

The historical data trend for ChromaDex's Days Inventory can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ChromaDex Days Inventory Chart

ChromaDex Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Days Inventory

Get a 7-Day Free Trial

175.94

176.68

177.75

176.42

162.53

ChromaDex Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Days Inventory	Get a 7-Day Free Trial															154.01	134.20	136.76	149.11	149.98

Competitive Comparison of ChromaDex's Days Inventory

For the Biotechnology subindustry, ChromaDex's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

ChromaDex's Days Inventory Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, ChromaDex's Days Inventory distribution charts can be found below:

* The bar in red indicates where ChromaDex's Days Inventory falls into.

ChromaDex Days Inventory Calculation

Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

ChromaDex's Days Inventory for the fiscal year that ended in Dec. 2023 is calculated as

	Days Inventory (A: Dec. 2023 )
=	Average Total Inventories					/	Cost of Goods Sold	*	Days in Period
=	( (Total Inventories (A: Dec. 2022 )	+	Total Inventories (A: Dec. 2023 ))	/	count )	/	Cost of Goods Sold (A: Dec. 2023 )	*	Days in Period
=	( (14.677	+	14.525)	/	2 )	/	32.79	*	365
=	14.601					/	32.79	*	365
=	162.53

ChromaDex's Days Inventory for the quarter that ended in Dec. 2023 is calculated as:

	Days Inventory (Q: Dec. 2023 )
=	Average Total Inventories					/	Cost of Goods Sold	*	Days in Period
=	( (Total Inventories (Q: Sep. 2023 )	+	Total Inventories (Q: Dec. 2023 ))	/	count )	/	Cost of Goods Sold (Q: Dec. 2023 )	*	Days in Period
=	( (12.624	+	14.525)	/	2 )	/	8.259	*	365 / 4
=	13.5745					/	8.259	*	365 / 4
=	149.98

ChromaDex (NAS:CDXC) Days Inventory Explanation

Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:

1. Inventory Turnover measures how fast the company turns over its inventory within a year.

ChromaDex's Inventory Turnover for the three months ended in Dec. 2023 is calculated as

Inventory Turnover	=	Cost of Goods Sold	/	Average Total Inventories
	=	8.259	/	13.5745
	=	0.61

2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

ChromaDex's Inventory to Revenue for the three months ended in Dec. 2023 is calculated as

Inventory-to-Revenue	=	Average Total Inventories	/	Revenue
	=	13.5745	/	21.196
	=	0.64

Be Aware

A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.

ChromaDex Days Inventory Related Terms

Thank you for viewing the detailed overview of ChromaDex's Days Inventory provided by GuruFocus.com. Please click on the following links to see related term pages.

ChromaDex (ChromaDex) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ChromaDex Corp (NAS:CDXC) » Definitions » Days Inventory

Comparable Companies

Traded in Other Exchanges

OCD1:Germany

Address

10900 Wilshire Boulevard, Suite 600, Los Angeles, CA, USA, 90024

Website

https://www.chromadex.com

ChromaDex Corp is a bioscience company dedicated to healthy aging. It is engaged in research on nicotinamide adenine dinucleotide (NAD+), levels of which decline with age. The company is the innovator behind NAD+ precursor nicotinamide riboside (NR), commercialized as the flagship ingredient Niagen. The company has three reportable segment namely Consumer Products, Ingredients segment and Analytical Reference Standards and Services. Majority of the revenue is earned from Consumer Products segment.

Executives

Brianna Gerber	officer: SVP Finance / Interim CFO	C/O CHROMADEX, INC., 1735 FLIGHT WAY, SUITE 200, TUSTIN CA 92782
Champion River Ventures Ltd	10 percent owner	C/O 7F, CHEUNG KONG CENTER, 2 QUEEN'S ROAD, CENTRAL K3 00000
Jaksch Frank L Jr	director, 10 percent owner, officer: Chief Executive Officer	10005 MUIRLANDS BOULEVARD, SUITE G FIRST FLOOR, IRVINE CA 92618
Robert N Fried	director	100 NORTH CRESCENT DRIVE, BEVERLY HILLS CA 90210
Steven D Rubin	director	OPKO HEALTH, INC., 4400 BISCAYNE BLVD., MIAMI FL 33137
Li Ka Shing	10 percent owner	79 DEEP WATER BAY ROAD, HONG KONG F4 00000
Chau Hoi Shuen Solina Holly	10 percent owner	SUITES PT. 2909 & 2910, HARBOUR CENTRE, 25 HARBOUR ROAD, WANCHAI K3 999077
Hamed Shahbazi	director	C/O CHROMADEX, INC., 1735 FLIGHT WAY, SUITE 200, TUSTIN CA 92782
Ann Cohen	director	C/O CHROMADEX CORPORATION, 10900 WILSHIRE BLVD. STE 600, LOS ANGELES CA 90024
Kristin Patrick	director	3329 CAY DRIVE, SHERMAN OAKS CA 91423
Ng Wang Yu Gary	director	ROOM 1709 HARBOUR CENTER, 25 HARBOUR ROAD, WANCHAI K3 -
Caroline S Levy	director	2424 N FEDERAL HIGHWAY, SUITE 208, BOCA RATON FL 33431
Stephen A Block	director	INTERNATIONAL FLAVORS & FRAGRANCES INC., 521 WEST 57TH ST, NEW YORK NY 10019
Lisa Hatton Harrington	officer: General Counsel	53 SEA TERRACE, NEWPORT COAST CA 92657
Kevin M Farr	officer: Chief Financial Officer	MATTEL, INC., 333 CONTINENTAL BLVD, M1-1518, EL SEGUNDO CA 90245